Centene (CNC) Stock Forecast, Price Target & Predictions
CNC Stock Forecast
Centene stock forecast is as follows: an average price target of $81.50 (represents a 36.79% upside from CNC’s last price of $59.58) and a rating consensus of 'Buy', based on 14 wall street analysts offering a 1-year stock forecast.
CNC Price Target
CNC Analyst Ratings
Buy
Centene Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Oct 29, 2024 | Andrew Mok | Barclays | $91.00 | $61.65 | 47.61% | 52.74% |
Sep 10, 2024 | David Windley | Jefferies | $72.00 | $71.00 | 1.41% | 20.85% |
Sep 05, 2024 | Andrew Mok | Barclays | $97.00 | $73.26 | 32.41% | 62.81% |
Jul 11, 2024 | David Windley | Jefferies | $83.00 | $66.38 | 25.04% | 39.31% |
Apr 29, 2024 | David Windley | Jefferies | $90.00 | $73.83 | 21.90% | 51.06% |
Apr 15, 2024 | Stephen Baxter | Wells Fargo | $93.00 | $73.02 | 27.36% | 56.09% |
Feb 08, 2023 | Goldman Sachs | $74.00 | $72.56 | 1.98% | 24.20% | |
Feb 08, 2023 | J.P. Morgan | $94.00 | $70.98 | 32.43% | 57.77% | |
Feb 08, 2023 | Barclays | $93.00 | $70.98 | 31.02% | 56.09% | |
Jan 06, 2023 | J.P. Morgan | $98.00 | $78.66 | 24.59% | 64.48% | |
Aug 26, 2022 | Stephen Baxter | Wells Fargo | $99.00 | $95.73 | 3.42% | 66.16% |
Jul 27, 2022 | Mizuho Securities | $92.00 | $91.58 | 0.46% | 54.41% | |
Jul 27, 2022 | Credit Suisse | $104.00 | $91.55 | 13.60% | 74.56% | |
Jul 26, 2022 | David MacDonald | Truist Financial | $102.00 | $91.93 | 10.95% | 71.20% |
Jun 22, 2022 | Deutsche Bank | $91.00 | $80.86 | 12.54% | 52.74% | |
Apr 27, 2022 | Morgan Stanley | $112.00 | $81.88 | 36.79% | 87.98% | |
Jan 05, 2022 | David S Macdonald | Truist Financial | $96.00 | $79.79 | 20.32% | 61.13% |
Dec 17, 2021 | Ricky Goldwasser | Morgan Stanley | $109.00 | $83.02 | 31.29% | 82.95% |
Dec 14, 2021 | Nathan Rich | Goldman Sachs | $83.00 | $81.85 | 1.41% | 39.31% |
Dec 13, 2021 | A.J. Rice | Credit Suisse | $86.00 | $78.15 | 10.04% | 44.34% |
Dec 13, 2021 | Scott Fidel | Stephens | $102.00 | $78.15 | 30.52% | 71.20% |
Dec 13, 2021 | Michael Wiederhorn | Oppenheimer | $95.00 | $78.15 | 21.56% | 59.45% |
Dec 13, 2021 | Kevin Fischbeck | Bank of America Securities | $93.00 | $78.15 | 19.00% | 56.09% |
Dec 13, 2021 | Justin Lake | Wolfe Research | $80.00 | $78.15 | 2.37% | 34.27% |
Jul 27, 2021 | Michael Newshel | Evercore ISI | $88.00 | $70.47 | 24.88% | 47.70% |
Centene Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 1 | 6 |
Avg Price Target | - | $91.00 | $87.67 |
Last Closing Price | $59.58 | $59.58 | $59.58 |
Upside/Downside | -100.00% | 52.74% | 47.15% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Oct 29, 2024 | Barclays | Overweight | Overweight | Hold |
Sep 10, 2024 | Jefferies | Hold | Hold | Hold |
Sep 05, 2024 | Barclays | Overweight | Overweight | Hold |
Aug 22, 2024 | Barclays | Equal-Weight | Equal-Weight | Hold |
Aug 19, 2024 | Wells Fargo | Buy | Buy | Hold |
Aug 05, 2024 | Wells Fargo | Overweight | Overweight | Hold |
Jul 29, 2024 | Wells Fargo | Buy | Buy | Hold |
Jul 24, 2024 | Cowen & Co. | Buy | Buy | Hold |
Jul 24, 2024 | Jefferies | Buy | Hold | Downgrade |
Jul 11, 2024 | Jefferies | Buy | Buy | Hold |
Jun 21, 2024 | Wells Fargo | Equal-Weight | Equal-Weight | Hold |
Jun 21, 2024 | Oppenheimer | Outperform | Outperform | Hold |
May 30, 2024 | Wells Fargo | Equal-Weight | Equal-Weight | Hold |
Apr 30, 2024 | Deutsche Bank | Hold | Hold | Hold |
Apr 29, 2024 | Jefferies | Buy | Buy | Hold |
Apr 15, 2024 | Wells Fargo | Equal-Weight | Equal-Weight | Hold |
Apr 15, 2024 | Wells Fargo | Overweight | Overweight | Hold |
Mar 25, 2024 | Stephens | Equal-Weight | Downgrade | |
Sep 05, 2023 | Craig-Hallum | Buy | Initialise | |
Sep 05, 2023 | BNP Paribas | Outperform | Initialise | |
Sep 05, 2023 | Bank of America Securities | Neutral | Upgrade | |
Mar 21, 2023 | Wells Fargo | Equal-Weight | Equal-Weight | Hold |
Mar 08, 2023 | Deutsche Bank | Buy | Hold | Downgrade |
Feb 24, 2023 | J.P. Morgan | Neutral | Downgrade | |
Feb 08, 2023 | Goldman Sachs | Neutral | Neutral | Hold |
Feb 08, 2023 | Barclays | Overweight | Overweight | Hold |
Aug 26, 2022 | Wells Fargo | Overweight | Downgrade | |
Jul 27, 2022 | Credit Suisse | Outperform | Outperform | Hold |
Jul 14, 2022 | Jefferies | Buy | Upgrade | |
Jun 22, 2022 | Deutsche Bank | Buy | Buy | Hold |
Jun 21, 2022 | Credit Suisse | Outperform | Upgrade | |
Apr 27, 2022 | Morgan Stanley | Overweight | Overweight | Hold |
Centene Financial Forecast
Centene Revenue Forecast
Quarter
Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $39.46B | - | $37.61B | $38.89B | $35.56B | $35.87B | $35.94B | $37.19B | $32.57B | $32.41B | $31.02B | $29.98B | $28.29B | $29.09B |
Avg Forecast | $77.83B | $74.23B | $70.79B | $67.51B | $43.28B | $44.37B | $43.06B | $43.93B | $42.09B | $42.71B | $42.28B | $41.94B | $39.27B | $37.93B | $36.83B | $36.43B | $36.14B | $36.24B | $36.56B | $36.14B | $35.40B | $35.50B | $35.56B | $34.52B | $32.50B | $31.62B | $30.19B | $29.49B | $28.32B | $28.25B |
High Forecast | $81.72B | $77.94B | $74.33B | $70.89B | $45.44B | $46.58B | $45.21B | $46.13B | $44.20B | $44.85B | $44.39B | $43.68B | $41.36B | $37.99B | $36.83B | $36.43B | $37.20B | $37.31B | $38.38B | $37.94B | $37.16B | $36.05B | $36.11B | $35.06B | $33.00B | $32.11B | $30.66B | $29.95B | $28.76B | $28.69B |
Low Forecast | $73.66B | $70.24B | $66.99B | $63.89B | $40.96B | $41.99B | $40.75B | $41.57B | $39.83B | $40.42B | $40.01B | $40.67B | $38.54B | $37.87B | $36.83B | $36.43B | $35.55B | $35.73B | $34.60B | $34.20B | $33.50B | $34.67B | $34.72B | $33.71B | $31.74B | $30.88B | $29.48B | $28.80B | $27.66B | $27.59B |
# Analysts | 6 | 3 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 7 | 9 | 4 | 3 | 3 | 6 | 13 | 6 | 6 | 5 | 5 | 5 | 11 | 12 | 11 | 10 | 9 | 9 | 8 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.09% | - | 1.03% | 1.08% | 1.00% | 1.01% | 1.01% | 1.08% | 1.00% | 1.02% | 1.03% | 1.02% | 1.00% | 1.03% |
Forecast
Centene EBITDA Forecast
Quarter
Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 6 | 3 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 7 | 9 | 4 | 3 | 3 | 6 | 13 | 6 | 6 | 5 | 5 | 5 | 11 | 12 | 11 | 10 | 9 | 9 | 8 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-194.00M | - | $1.17B | $1.58B | $649.00M | $1.16B | $1.72B | $1.64B | $1.24B | $1.27B | $-23.00M | $1.47B | $453.00M | $1.26B |
Avg Forecast | $2.75B | $2.62B | $2.50B | $2.39B | $1.53B | $1.57B | $1.52B | $1.55B | $1.49B | $1.51B | $1.49B | $1.48B | $1.39B | $1.34B | $1.30B | $1.87B | $1.28B | $1.28B | $1.29B | $1.70B | $1.32B | $1.20B | $1.20B | $1.54B | $1.09B | $1.06B | $1.02B | $1.44B | $953.75M | $951.27M |
High Forecast | $2.89B | $2.76B | $2.63B | $2.51B | $1.61B | $1.65B | $1.60B | $1.63B | $1.56B | $1.59B | $1.57B | $1.54B | $1.46B | $1.34B | $1.30B | $2.24B | $1.32B | $1.32B | $1.36B | $2.04B | $1.59B | $1.21B | $1.22B | $1.85B | $1.11B | $1.08B | $1.03B | $1.72B | $968.59M | $966.06M |
Low Forecast | $2.60B | $2.48B | $2.37B | $2.26B | $1.45B | $1.48B | $1.44B | $1.47B | $1.41B | $1.43B | $1.41B | $1.44B | $1.36B | $1.34B | $1.30B | $1.49B | $1.26B | $1.26B | $1.22B | $1.36B | $1.06B | $1.17B | $1.17B | $1.23B | $1.07B | $1.04B | $992.81M | $1.15B | $931.37M | $928.94M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.15% | - | 0.91% | 0.93% | 0.49% | 0.97% | 1.43% | 1.06% | 1.13% | 1.20% | -0.02% | 1.03% | 0.47% | 1.32% |
Forecast
Centene Net Income Forecast
Quarter
Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 6 | 3 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 7 | 9 | 4 | 3 | 3 | 6 | 13 | 6 | 6 | 5 | 5 | 5 | 11 | 12 | 11 | 10 | 9 | 9 | 8 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $45.00M | - | $1.06B | $1.13B | $-219.00M | $738.00M | $-171.00M | $849.00M | $593.00M | $584.00M | $-535.00M | $699.00M | $-12.00M | $568.00M |
Avg Forecast | $471.55M | $1.04B | $1.22B | $1.07B | $534.45M | $1.15B | $1.29B | $1.28B | $421.14M | $982.93M | $1.17B | $1.16B | $240.48M | $709.25M | $1.11B | $935.57M | $219.90M | $811.45M | $1.07B | $850.52M | $638.73M | $654.81M | $848.74M | $773.20M | $518.25M | $660.28M | $643.37M | $681.42M | $249.66M | $511.30M |
High Forecast | $502.20M | $1.11B | $1.30B | $1.14B | $569.18M | $1.22B | $1.38B | $1.36B | $448.51M | $1.05B | $1.25B | $1.22B | $278.95M | $755.35M | $1.11B | $1.12B | $271.04M | $930.33M | $1.14B | $1.02B | $766.48M | $664.87M | $865.90M | $927.84M | $528.73M | $660.61M | $656.38M | $817.70M | $254.70M | $521.64M |
Low Forecast | $438.67M | $969.52M | $1.13B | $997.77M | $497.17M | $1.07B | $1.20B | $1.19B | $391.76M | $914.37M | $1.09B | $996.75M | $211.62M | $659.78M | $1.11B | $748.45M | $194.33M | $651.23M | $999.21M | $680.41M | $510.98M | $644.76M | $822.85M | $618.56M | $502.44M | $659.94M | $623.74M | $545.13M | $242.04M | $495.70M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.20% | - | 0.98% | 1.33% | -0.34% | 1.13% | -0.20% | 1.10% | 1.14% | 0.88% | -0.83% | 1.03% | -0.05% | 1.11% |
Forecast
Centene SG&A Forecast
Quarter
Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 6 | 3 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 7 | 9 | 4 | 3 | 3 | 6 | 13 | 6 | 6 | 5 | 5 | 5 | 11 | 12 | 11 | 10 | 9 | 9 | 8 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $3.49B | - | $3.02B | $3.01B | $3.20B | $2.85B | $2.80B | $2.75B | $2.84B | $2.68B | $2.27B | $2.37B | $3.10B | $2.88B |
Avg Forecast | $6.73B | $6.41B | $6.12B | $5.83B | $3.74B | $3.83B | $3.72B | $3.80B | $3.64B | $3.69B | $3.65B | $3.62B | $3.39B | $3.28B | $3.18B | $3.02B | $3.12B | $3.13B | $3.16B | $2.75B | $3.03B | $3.07B | $3.07B | $2.50B | $2.81B | $2.73B | $2.61B | $2.31B | $2.45B | $2.44B |
High Forecast | $7.06B | $6.73B | $6.42B | $6.13B | $3.93B | $4.03B | $3.91B | $3.99B | $3.82B | $3.88B | $3.84B | $3.77B | $3.57B | $3.28B | $3.18B | $3.63B | $3.21B | $3.22B | $3.32B | $3.30B | $3.64B | $3.12B | $3.12B | $3.00B | $2.85B | $2.77B | $2.65B | $2.77B | $2.49B | $2.48B |
Low Forecast | $6.36B | $6.07B | $5.79B | $5.52B | $3.54B | $3.63B | $3.52B | $3.59B | $3.44B | $3.49B | $3.46B | $3.51B | $3.33B | $3.27B | $3.18B | $2.42B | $3.07B | $3.09B | $2.99B | $2.20B | $2.42B | $3.00B | $3.00B | $2.00B | $2.74B | $2.67B | $2.55B | $1.85B | $2.39B | $2.38B |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.12% | - | 0.95% | 1.09% | 1.06% | 0.93% | 0.91% | 1.10% | 1.01% | 0.98% | 0.87% | 1.03% | 1.27% | 1.18% |
Forecast
Centene EPS Forecast
Quarter
Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 6 | 3 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 5 | 2 | 7 | 9 | 4 | 3 | 3 | 6 | 13 | 6 | 6 | 5 | 5 | 5 | 11 | 12 | 11 | 10 | 9 | 9 | 8 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.08 | - | - | $2.05 | $-0.39 | $1.29 | $-0.29 | $1.46 | $1.02 | $1.00 | $-0.92 | $1.20 | $-0.02 | $0.98 |
Avg Forecast | $0.90 | $1.99 | $2.33 | $2.05 | $1.02 | $2.20 | $2.47 | $2.45 | $0.80 | $1.88 | $2.23 | $2.22 | $0.46 | $1.35 | $2.12 | $2.06 | $0.42 | $1.55 | $2.05 | $2.00 | $0.82 | $1.23 | $1.60 | $1.68 | $0.98 | $1.24 | $1.21 | $1.50 | $0.47 | $0.96 |
High Forecast | $0.96 | $2.12 | $2.48 | $2.18 | $1.09 | $2.34 | $2.63 | $2.60 | $0.86 | $2.00 | $2.38 | $2.33 | $0.53 | $1.44 | $2.12 | $2.06 | $0.52 | $1.78 | $2.18 | $2.13 | $0.87 | $1.25 | $1.63 | $1.72 | $1.00 | $1.24 | $1.24 | $1.53 | $0.48 | $0.98 |
Low Forecast | $0.84 | $1.85 | $2.17 | $1.91 | $0.95 | $2.04 | $2.30 | $2.27 | $0.75 | $1.75 | $2.08 | $1.90 | $0.40 | $1.26 | $2.12 | $2.06 | $0.37 | $1.24 | $1.91 | $1.86 | $0.76 | $1.21 | $1.55 | $1.63 | $0.95 | $1.24 | $1.18 | $1.46 | $0.46 | $0.93 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.20% | - | 0.00% | 1.02% | -0.48% | 1.05% | -0.18% | 0.87% | 1.04% | 0.80% | -0.76% | 0.80% | -0.04% | 1.02% |
Forecast
Centene Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
OSCR | Oscar Health | $13.50 | $28.00 | 107.41% | Buy |
CVS | CVS Health | $44.04 | $73.50 | 66.89% | Buy |
CI | Cigna | $265.59 | $400.00 | 50.61% | Buy |
ELV | Elevance Health | $366.30 | $542.14 | 48.00% | Buy |
CNC | Centene | $57.81 | $81.50 | 40.98% | Buy |
UNH | UnitedHealth Group | $485.52 | $618.75 | 27.44% | Buy |
HUM | Humana | $233.89 | $292.13 | 24.90% | Hold |
MOH | Molina Healthcare | $291.78 | $347.00 | 18.93% | Hold |
ALHC | Alignment Healthcare | $10.83 | $10.00 | -7.66% | Buy |